Kenneth P. Lyons

Factors affecting sensitivity and specificity of a diagnostic test: the exercise thallium scintigram☆

Technical and methodological factors might affect the reported accuracies of diagnostic tests. To assess their influence on the accuracy of exercise thallium scintigraphy, the medical literature (1977 to 1986) was non-selectively searched and meta-analysis was applied to the 56 publications thus retrieved. These were analyzed for year of publication, sex and mean age of patients, percentage of patients with angina pectoris, percentage of patients with prior myocardial infarction, percentage of patients taking beta-blocking medications, and for angiographic referral (workup) bias, blinding of tests, and technical factors. The percentage of patients with myocardial infarction had the highest correlation with sensitivity (0.45, p = 0.0007). Only the inclusion of subjects with prior infarction and the percentage of men in the study group were independently and significantly (p less than 0.05) related to test sensitivity. Both the presence of workup bias and publication year adversely affected specificity (p less than 0.05). Of these two factors, publication year had the strongest association by stepwise linear regression. This analysis suggests that the reported sensitivity of thallium scintigraphy is higher and the specificity lower than that expected in clinical practice because of the presence of workup bias and the inappropriate inclusion of post-infarct patients.

A randomized controlled trial of intravenous streptokinase in evolving acute myocardial infarction

To determine the efficacy of intravenous streptokinase in acute myocardial infarction, 52 patients were randomized to intravenous streptokinase or control groups. Time from onset of infarction to randomization was similar in the streptokinase group and control group, 4.9 +/- 2.1 hours vs 5.4 +/- 2.4 hours, respectively. The 28 streptokinase patients received an intravenous infusion of 700,000 units of streptokinase followed by full-dose anticoagulation. The 24 control patients received normal saline solution followed by full-dose anticoagulation. Of 28 streptokinase patients, 12 (43%) had noninvasive evidence of reperfusion by early peaking of serum creatine kinase (peak creatine kinase less than 16 hours after onset of infarction) vs 3 of 24 control patients (13%), p less than 0.02. Two streptokinase patients (7%) had reperfusion arrhythmias during streptokinase infusion. One streptokinase patient (4%) and two control patients (8%) died during hospitalization. At angiography (16 +/- 5 days after infarction) 22 of 26 streptokinase patients (85%) had a patent infarct-related coronary artery compared to 8 of 20 control patients (40%), p less than 0.01. Comparison of radionuclide left ventricular ejection fraction assessed acutely (28 +/- 10 hours after infarction) with left ventricular ejection fraction at hospital discharge (15 +/- 3 days after infarction) showed no significant improvement in either the streptokinase or control group, 0% and +1%, respectively. At follow-up 13 +/- 7 months after infarction, total mortality rate was similar in the streptokinase group and control group, 17.8% (5 of 28 streptokinase patients) and 20.8% (5 of 24 control patients), respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Prognostic Value of a Persistently Positive Technetium-99m Stannous Pyrophosphate Myocardial Scintigram After Myocardial Infarction

Technetium-99m stannous pyrophosphate myocardial scintigrams were obtained in 138 clinically stable patients 32.7 +/- 47.3 weeks (range 6 to 260) after acute myocardial infarction. Of the 138 patients, 74 (54 percent) had a persistently positive scintigram. Patients with such a scintigram were more likely to have severe angina pectoris, compensated congestive heart failure, anterior location of acute myocardial infarction, Q waves and S-T segment elevation in the electrocardiograms, cardiomegaly, left ventricular dyssynergy (dyskinesia or global dyssynergy), and an ejection fraction of less than 50 percent. During a follow-up period of 11.6 +/- 6.9 months after scintigraphy, 42 percent of the patients with a persistently positive scintigram had either a cardiac death, a nonfatal myocardial infarction, unstable angina pectoris or decompensated congestive heart failure compared with 13 percent of the patients with a negative scintigram (P less than 0.001). Of the 14 patients with cardiac death, 13 (93 percent) had a persistently positive scintigram. A persistently positive scintigram not only was the best single predictor of cardiac death and combined end points, but also added significantly to the predictive ability of the other clinical variables, including age, location of acute myocardial infarct, clinical status, electrocardiographic findings, and chest X-ray findings. It is concluded that technetium-99m stannous pyrophosphate myocardial scintigraphy has prognostic value in patients after acute myocardial infarction.

Prognostic implications of complicated ventricular arrhythmias early after hospital discharge in acute myocardial infarction: A serial ambulatory electrocardiography study

To assess the prevalence and prognostic implications of complicated ventricular ectopic depolarizations (VEDs) after hospital discharge in patients with acute myocardial infarction (AMI), we obtained serial 24-hour Holter recordings in 85 patients during the first 6 weeks after AMI. Recordings were obtained during two coronary care unit time intervals, two hospital ward time intervals, and during four weekly time intervals after discharge. Complicated VEDs were defined as unifocal VEDs greater than or equal to 10/1000 beats for 24 hours, multiform VEDs, pairs, or ventricular tachycardia. At 1 year follow-up, there were nine cardiac deaths (six sudden deaths and three deaths from recurrent AMI). The mean left ventricular ejection fraction at discharge in the cardiac death patients was 29 +/- 12% (sudden death patients 24 +/- 11% and AMI death patients 40 +/- 6%) compared to 49 +/- 13% in the survivors (p less than 0.001). Patients with complicated VEDs at discharge (2 weeks after AMI) or during the first 4 weeks after discharge (3 to 6 weeks after AMI) were significantly more likely to have sudden death at follow-up compared to patients without complicated VEDs. Of the six sudden death patients, four (66%) had complicated VEDs at discharge compared to 18 of 68 survivors (26%) (p less than 0.05). One of three patients who died of recurrent AMI had complicated VEDs. No Holter data were obtained at hospital discharge in eight of the survivors.(ABSTRACT TRUNCATED AT 250 WORDS)

Pyrophosphate myocardial imaging

Technetium-99m pyrophosphate myocardial scintigraphy is a sensitive indicator of acute myocardial infarction (AMI). Over 90% of acute myocardial infarctions will result in an abnormal scintigram. The sensitivity is highest for transmural myocardial infarction, reaching levels of 95% or better. The positivity rate for subendocardial infarction ranges from 40% to 88% depending on the criteria used for interpreting the study. The threshold for positivity may be established using the intensity level present within the myocardium, on the presence or absence of localization within a specific wall of the myocardium, or a combination of both. The more stringent the criteria and the higher the threshold for positivity, the greater will be the specificity for acute infarction. The high specificity will, however, be at the expense of a lower sensitivity. Several other pathologic conditions can yield a positive myocardial scintiphotogram. Most commonly these are other forms of coronary artery disease in which frank myocardial infarction is not occurring. The cause of positive scintiphotograms in the absence of acute myocardial infarction is not known. It may be that with ischemia there are small focal areas of necrosis or that pyrophosphate concentration occurs purely on the basis of the ischemia. In the absence of infarction, the pattern of positivity is usually diffuse rather than localized in a specific wall. There are exceptions to this, most notably with ventricular aneurysms; however, the presence of a localized abnormality generally increases the specificity of a positive scintiphotogram for AMI. A positive scintigram in the absence of acute infarction has prognostic value in coronary artery disease for some conditions. A persistently positive study following a remote infarction is associated with an increased morbidity and mortality. Likewise, a positive scintiphotogram before coronary artery bypass surgery portends a higher surgical risk. Other indications for the examination include the diagnosis of perioperative infarction and right ventricular infarction. Less common entities such as metastasis to the myocardium, myocardial trauma, radiation therapy, or any other entity leading to significant myocardial injury or cellular death may result in an abnormal scintiphotogram.

Dental lesions causing abnormalities on skeletal scintigraphy.

&NA; The dental lesions of periodontitis, periodontal cysts, and tooth extraction were studied by Tc‐99m phosphate scintigraphy of the jaws. Inflamed apical periodontal lesions caused a localized area of increased concentration of radiotracer regardless of the presence or absence of symptoms. Scintigrams may be positive up to eight months after dental extractions but tend to return to normal thereafter unless complications arise.

Technetium-99m stannous pyrophosphate myocardial scintigrams in pericardial disease.

Technetium-99m stannous pyrophosphate (99mTc-PYP) myocardial scintigrams were obtained in 35 acute pericarditis and in three chronic constrictive pericarditis patients. Thirteen of 35 acute pericarditis patients (37%) and one of three chronic constrictive pericarditis patients (33%) had abnormal scintigrams (a diffuse pattern in eight patients and a regional pattern in six patients). Of the 17 acute pericarditis patients with classic ST-segment changes of acute pericarditis, 10 (56%) had abnormal scintigrams compared to three of 17 patients (18%) without these ECG changes (P less than 0.02). These data indicate that pericardial disease may cause an abnormal scintigram. Therefore, one must rule out pericardial disease before concluding that a positive scintigram is due to acute myocardial infarction.

Silicon avalanche radiation detectors: The basis for a new in vivo radiation detection probe

Recent advances in semiconductor technology have made it possible to develop practical silicon avalanche radiation detectors. These detectors are analogous in operation to a gas proportional counter, but are capable of extreme miniaturization. Most importantly these devices have overcome the in vivo limitations of past semiconductor detectors with respect to noise, microphonics, and adaptability to relatively harsh environments. The operation and some useful characteristics of an avalanche detector are outlined. The performance of a probe mounted detector in an in vivo setting is described which illustrates one application of the silicon avalanche detector in this milieu.

Comparison of thallium-201 single-photon emission computed tomographic scintigraphy with intravenous dipyridamole and arm exercise

In patients who cannot perform treadmill exercise, both intravenous dipyridamole and arm exercise have been used with thallium-201 scintigraphy to detect significant coronary artery disease. However, no study has directly evaluated the results of intravenous dipyridamole and arm exercise thallium scintigraphy as compared with coronary angiography. It was the purpose of this study to compare intravenous dipyridamole and arm exercise thallium-201 single-photon emission computed tomographic (SPECT) scintigraphy for detection of significant coronary artery disease in patients who could not perform treadmill exercise. Data are presented for both intravenous dipyridamole and arm exercise thallium-201 SPECT scintigraphy in 18 men who could not perform treadmill exercise, and results are compared with those of coronary angiography. Ten of 11 (91%) patients with significant coronary artery disease were identified correctly, and the results of intravenous dipyridamole and arm exercise thallium scintigraphy were comparable. In patients without significant coronary artery disease, intravenous dipyridamole thallium images were interpreted correctly. However, initial arm exercise thallium images demonstrated a fixed inferior wall defect in two of seven patients without significant coronary artery disease. Images in one of these patients could not be retrieved from tape for further analysis. Review of the images in the other patient demonstrated relatively high background radioactivity, and when the images were displayed without background subtraction, the inferior wall was correctly interpreted as normal. We conclude that results of intravenous dipyridamole and arm exercise thallium-201 SPECT scintigraphy are comparable.

Adenosine challenge and boost protocols: new tools for myocardial perfusion imaging.

The validity of pharmacologic stress testing and subsequent myocardial perfusion imaging is uncertain in those patients who may have taken caffeine within the 24 hours before testing. For such patients, two new challenge tests have been developed. An intravenous bolus dose of adenosine is given at a dose of 6 mg in a period of 1 or 2 seconds. A physiologic response qualifies the patient to proceed with the scheduled stress test. In the occasional patient who exhibits no pharmacologic symptoms during an infusion test, a similar bolus dose of 6 mg adenosine can validate perfusion tests. These two applications are successful regardless of whether adenosine or dipyridamole infusions are performed. Based on this multicenter experience over 4 years, the authors estimate that 5% to 10% of patients undergoing pharmacologic testing are appropriate candidates for a challenge test.